Inflammation in human carotid atheroma plaques

Area of Science:

• Cardiovascular Science
• Inflammation Research
• Atherosclerosis Studies

Background:

• Inflammation within carotid atherosclerotic plaque is a significant risk factor for plaque rupture and subsequent cerebrovascular accidents.
• The interplay between pro-inflammatory and anti-inflammatory mediators critically influences atherosclerotic lesion development and progression.
• Smooth muscle cells (SMCs) are the predominant cell type in advanced plaques and play a crucial role in carotid atherosclerosis.

Purpose of the Study:

• To review the stages of carotid atheroma plaque formation, from early fatty streaks to advanced, rupture-prone lesions.
• To document the involvement of cytokines and chemokines in plaque progression and rupture.
• To highlight the role of smooth muscle cells (SMCs) in carotid plaque inflammation.

Main Methods:

• Literature review of carotid atheroma plaque formation.
• Analysis of the role of cytokines and chemokines in plaque progression.
• Examination of smooth muscle cell (SMC) phenotypes and inflammatory mediator production.

Main Results:

• Smooth muscle cells (SMCs) in carotid atheroma actively contribute to plaque inflammation.
• SMCs acquire the capacity to produce inflammatory mediators within the lesion environment.
• Cytokines and chemokines are key mediators in plaque progression and rupture dynamics.

Conclusions:

• Smooth muscle cells (SMCs) are critical players in carotid atherosclerosis, contributing significantly to plaque inflammation.
• The inflammatory environment of the lesion drives SMC differentiation and mediator production.
• Targeting inflammatory pathways involving SMCs, cytokines, and chemokines may offer therapeutic strategies for carotid atherosclerosis.